158 related articles for article (PubMed ID: 31190442)
1. Quality of life in pediatric acute myeloid leukemia: Report from the Children's Oncology Group.
Nagarajan R; Gerbing R; Alonzo T; Johnston DL; Aplenc R; Kolb EA; Meshinchi S; Barakat LP; Sung L
Cancer Med; 2019 Aug; 8(9):4454-4464. PubMed ID: 31190442
[TBL] [Abstract][Full Text] [Related]
2. Reasons for non-completion of health related quality of life evaluations in pediatric acute myeloid leukemia: a report from the Children's Oncology Group.
Johnston DL; Nagarajan R; Caparas M; Schulte F; Cullen P; Aplenc R; Sung L
PLoS One; 2013; 8(9):e74549. PubMed ID: 24040278
[TBL] [Abstract][Full Text] [Related]
3. Patient-Reported Outcome Coordinator Did Not Improve Quality of Life Assessment Response Rates: A Report from the Children's Oncology Group.
Johnston D; Gerbing R; Alonzo T; Aplenc R; Nagarajan R; Schulte F; Cullen P; Sung L
PLoS One; 2015; 10(4):e0125290. PubMed ID: 25915772
[TBL] [Abstract][Full Text] [Related]
4. Rates of laboratory adverse events by course in paediatric leukaemia ascertained with automated electronic health record extraction: a retrospective cohort study from the Children's Oncology Group.
Miller TP; Getz KD; Li Y; Demissei BG; Adamson PC; Alonzo TA; Burrows E; Cao L; Castellino SM; Daves MH; Fisher BT; Gerbing R; Grundmeier RW; Krause EM; Lee J; Lupo PJ; Rabin KR; Ramos M; Scheurer ME; Wilkes JJ; Winestone LE; Hawkins DS; Gramatges MM; Aplenc R
Lancet Haematol; 2022 Sep; 9(9):e678-e688. PubMed ID: 35870472
[TBL] [Abstract][Full Text] [Related]
5. The PedsQL in pediatric cancer: reliability and validity of the Pediatric Quality of Life Inventory Generic Core Scales, Multidimensional Fatigue Scale, and Cancer Module.
Varni JW; Burwinkle TM; Katz ER; Meeske K; Dickinson P
Cancer; 2002 Apr; 94(7):2090-106. PubMed ID: 11932914
[TBL] [Abstract][Full Text] [Related]
6. Bortezomib with standard chemotherapy for children with acute myeloid leukemia does not improve treatment outcomes: a report from the Children's Oncology Group.
Aplenc R; Meshinchi S; Sung L; Alonzo T; Choi J; Fisher B; Gerbing R; Hirsch B; Horton T; Kahwash S; Levine J; Loken M; Brodersen L; Pollard J; Raimondi S; Kolb EA; Gamis A
Haematologica; 2020 Jul; 105(7):1879-1886. PubMed ID: 32029509
[TBL] [Abstract][Full Text] [Related]
7. The PedsQL as a patient-reported outcome in children and adolescents with fibromyalgia: an analysis of OMERACT domains.
Varni JW; Burwinkle TM; Limbers CA; Szer IS
Health Qual Life Outcomes; 2007 Feb; 5():9. PubMed ID: 17295915
[TBL] [Abstract][Full Text] [Related]
8. Validation of the Functional Assessment of Cancer Therapy-Leukemia instrument in patients with acute myeloid leukemia who are not candidates for intensive therapy.
Peipert JD; Yount SE; Efficace F; Loefgren C; Pierson R; He J; Cella D
Cancer; 2020 Aug; 126(15):3542-3551. PubMed ID: 32463931
[TBL] [Abstract][Full Text] [Related]
9. Sorafenib in Combination With Standard Chemotherapy for Children With High Allelic Ratio
Pollard JA; Alonzo TA; Gerbing R; Brown P; Fox E; Choi J; Fisher B; Hirsch B; Kahwash S; Getz K; Levine J; Brodersen LE; Loken MR; Raimondi S; Tarlock K; Wood A; Sung L; Kolb EA; Gamis A; Meshinchi S; Aplenc R
J Clin Oncol; 2022 Jun; 40(18):2023-2035. PubMed ID: 35349331
[TBL] [Abstract][Full Text] [Related]
10. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
11. Medical Outcomes, Quality of Life, and Family Perceptions for Outpatient vs Inpatient Neutropenia Management After Chemotherapy for Pediatric Acute Myeloid Leukemia.
Getz KD; Szymczak JE; Li Y; Madding R; Huang YV; Aftandilian C; Arnold SD; Bona KO; Caywood E; Collier AB; Gramatges MM; Henry M; Lotterman C; Maloney K; Mian A; Mody R; Morgan E; Raetz EA; Rubnitz J; Verma A; Winick N; Wilkes JJ; Yu JC; Fisher BT; Aplenc R
JAMA Netw Open; 2021 Oct; 4(10):e2128385. PubMed ID: 34709389
[TBL] [Abstract][Full Text] [Related]
12. Health-related Quality of Life (HR-QOL) and Chronic Health Conditions in Survivors of Childhood Acute Myeloid Leukemia (AML) with Down Syndrome (DS): A Report From the Children's Oncology Group.
Schultz KA; Chen L; Kunin-Batson A; Chen Z; Woods WG; Gamis A; Kawashima T; Oeffinger KC; Nicholson HS; Neglia JP
J Pediatr Hematol Oncol; 2017 Jan; 39(1):20-25. PubMed ID: 27906794
[TBL] [Abstract][Full Text] [Related]
13. Association between prolonged neutropenia and reduced relapse risk in pediatric AML: A report from the children's oncology group.
Sung L; Aplenc R; Alonzo TA; Gerbing RB; Wang YC; Meshinchi S; Gamis AS
Int J Cancer; 2016 Nov; 139(9):1930-5. PubMed ID: 27312107
[TBL] [Abstract][Full Text] [Related]
14. Parent proxy-report of their children's health-related quality of life: an analysis of 13,878 parents' reliability and validity across age subgroups using the PedsQL 4.0 Generic Core Scales.
Varni JW; Limbers CA; Burwinkle TM
Health Qual Life Outcomes; 2007 Jan; 5():2. PubMed ID: 17201923
[TBL] [Abstract][Full Text] [Related]
15. Health conditions and quality of life in survivors of childhood acute myeloid leukemia comparing post remission chemotherapy to BMT: a report from the children's oncology group.
Schultz KA; Chen L; Chen Z; Kawashima T; Oeffinger KC; Woods WG; Nicholson HS; Neglia JP
Pediatr Blood Cancer; 2014 Apr; 61(4):729-36. PubMed ID: 24285698
[TBL] [Abstract][Full Text] [Related]
16. Interleukin-2 as maintenance therapy for children and adults with acute myeloid leukaemia in first complete remission.
Mao C; Fu XH; Yuan JQ; Yang ZY; Huang YF; Ye QL; Wu XY; Hu XF; Zhai ZM; Tang JL
Cochrane Database Syst Rev; 2015 Nov; 2015(11):CD010248. PubMed ID: 26544114
[TBL] [Abstract][Full Text] [Related]
17. Parent proxy-reported health-related quality of life and fatigue in pediatric patients diagnosed with brain tumors and acute lymphoblastic leukemia.
Meeske K; Katz ER; Palmer SN; Burwinkle T; Varni JW
Cancer; 2004 Nov; 101(9):2116-25. PubMed ID: 15389475
[TBL] [Abstract][Full Text] [Related]
18. Proteasome subunit expression analysis and chemosensitivity in relapsed paediatric acute leukaemia patients receiving bortezomib-containing chemotherapy.
Niewerth D; Kaspers GJ; Jansen G; van Meerloo J; Zweegman S; Jenkins G; Whitlock JA; Hunger SP; Lu X; Alonzo TA; van de Ven PM; Horton TM; Cloos J
J Hematol Oncol; 2016 Sep; 9(1):82. PubMed ID: 27599459
[TBL] [Abstract][Full Text] [Related]
19. Quality of life and physical function in adults treated with intensive chemotherapy for acute myeloid leukemia improve over time independent of age.
Alibhai SM; Breunis H; Timilshina N; Brignardello-Petersen R; Tomlinson G; Mohamedali H; Gupta V; Minden MD; Li M; Buckstein R; Brandwein JM
J Geriatr Oncol; 2015 Jul; 6(4):262-71. PubMed ID: 25944029
[TBL] [Abstract][Full Text] [Related]
20. Combination of sorafenib, vorinostat and bortezomib for the treatment of poor-risk AML: report of two consecutive clinical trials.
Sayar H; Cripe LD; Saliba AN; Abu Zaid M; Konig H; Boswell HS
Leuk Res; 2019 Feb; 77():30-33. PubMed ID: 30626561
[No Abstract] [Full Text] [Related]
[Next] [New Search]
